Frovocimab, CAS [[1643672-70-1]]

Product Overview

• Article Name: Frovocimab, CAS [[1643672-70-1]]
• Biozol Catalog Number: TGM-T77014
• Supplier Catalog Number: T77014
• Alternative Catalog Number: TGM-T77014-1MG,TGM-T77014-5MG,TGM-T77014-10MG,TGM-T77014-25MG,TGM-T77014-50MG,TGM-T77014-100MG
• Manufacturer: TargetMol
• Category: Biochemikalien
• Alternative Names: LY3015014 , LY 3015014

Product Description

Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia. Frovocimab is used to study hypercholesterolemia.

Product Properties

• Purity: 95.30%
• CAS Number: [1643672-70-1]
• Target: Others